Connecting chemosensitivity, gene expression and disease

被引:4
作者
Covell, David G. [1 ]
机构
[1] NCI, Div Canc Treatment & Diagnosis, Dev Therapeut Program, Screening Technol Branch,Lab Computat Technol, Frederick, MD 21702 USA
关键词
D O I
10.1016/j.tips.2007.10.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Omics-based investigations offer potentially powerful readouts that might be useful for probing the underlying biology of normal and diseased states, identifying novel therapeutic targets and proposing relevant markers for designing treatment strategies. A vital component of these investigations involves a systematic analysis of gene expression and chemosensitivity data in the context of disease states and small molecule probes into the function of targets responsible for a disease phenotype. Systematic analysis of chemical and pharmacogenetics data offers a possible means to identify novel, small-molecule, potentially therapeutic, agents that affect the phenotype of a particular target. Elegantly simple in concept, the covariation of genetic and chemosensitivity readouts provide a hypothetical link for relating compounds through genomic expression profiles to underlying biology.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 55 条
[1]  
Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004
[2]   MicroRNA expression profiles for the NCI-60 cancer cell panel [J].
Blower, Paul E. ;
Verducci, Joseph S. ;
Lin, Shili ;
Zhou, Jin ;
Chung, Ji-Hyun ;
Dai, Zunyan ;
Liu, Chang-Gong ;
Reinhold, William ;
Lorenzi, Philip L. ;
Kaldjian, Eric P. ;
Croce, Carlo M. ;
Weinstein, John N. ;
Sadee, Wolfgang .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (05) :1483-1491
[3]   Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profiles [J].
Bock-Axelsen, Jacob ;
Lotem, Joseph ;
Sachs, Leo ;
Dornany, Eytan .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (32) :13122-13127
[4]   SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN [J].
BOYD, MR ;
PAULI, KD .
DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) :91-109
[5]   Target identification in chemical genetics: The (often) missing link [J].
Burdine, L ;
Kodadek, T .
CHEMISTRY & BIOLOGY, 2004, 11 (05) :593-597
[6]   Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel [J].
Bussey, KJ ;
Chin, K ;
Lababidi, S ;
Reimers, M ;
Reinhold, WC ;
Kuo, WL ;
Gwadry, F ;
Jain, A ;
Kouros-Mehr, H ;
Fridlyand, J ;
Jain, A ;
Collins, C ;
Nishizuka, S ;
Tonon, G ;
Roschke, A ;
Gehlhaus, K ;
Kirsch, I ;
Scudiero, DA ;
Gray, JW ;
Weinstein, JN .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (04) :853-867
[7]   Genomics and proteomics: Emerging technologies in clinical cancer research [J].
Chung, Christine H. ;
Levy, Shawn ;
Chaurand, Pierre ;
Carbone, David P. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 61 (01) :1-25
[8]   Linking tumor cell cytotoxicity to mechanism of drug action: An integrated analysis of gene expression, small-molecule screening and structural databases [J].
Covell, DG ;
Wallqvist, A ;
Huang, RL ;
Thanki, N ;
Rabow, AA ;
Lu, XJ .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2005, 59 (03) :403-433
[9]   Developing global insight into RNA regulation [J].
Darnell, R. B. .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 2006, 71 :321-327
[10]   The role of the informatics framework in early lead discovery [J].
Fay, Nicolas .
DRUG DISCOVERY TODAY, 2006, 11 (23-24) :1075-1084